Page last updated: 2024-08-18

acrolein and Cardiomyopathy, Congestive

acrolein has been researched along with Cardiomyopathy, Congestive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Pan, W; Wan, J; Wang, M; Wei, C; Xu, Y; Yin, Z; Zhang, J; Zhao, M; Zheng, Z1
Bhatnagar, A; Chandrasekar, B; Gu, Y; Haberzettl, P; Hamid, T; Ismahil, MA; Prabhu, SD; Srivastava, S1

Other Studies

2 other study(ies) available for acrolein and Cardiomyopathy, Congestive

ArticleYear
TRPA1 deficiency aggravates dilated cardiomyopathy by promoting S100A8 expression to induce M1 macrophage polarization in rats.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2023, Volume: 37, Issue:6

    Topics: Acrolein; Animals; Calgranulin A; Cardiomyopathy, Dilated; Cytoskeletal Proteins; Doxorubicin; Humans; Macrophages; Myocytes, Cardiac; Rats; TRPA1 Cation Channel

2023
Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:5

    Topics: Acrolein; Administration, Oral; Animals; Apoptosis; Cardiomyopathy, Dilated; Environmental Pollutants; Gene Expression Regulation; Hypertrophy, Left Ventricular; Immunohistochemistry; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocarditis; Myocardium; Oxidative Stress; Real-Time Polymerase Chain Reaction; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2011